ArticlePDF AvailableLiterature Review

Abstract and Figures

Eight decades ago, Al exander Randall identified calcium phosphate deposits at the tip of renal papillae as the origin of renal calculi. The awareness that these “Randall’s plaque” promote renal stone formation has been amplified during the past years by the development of endoscopic procedures allowing the in situ visualization of these plaques. Recent studies based upon kidney biopsies evidenced that apatite deposits at the origin of these plaque originate from the basement membranes of thin loops of Henle and then spread in the surrounding interstitium. In addition, scanning electron microscopy examination of calcium oxalate stones developed on Randall’s plaque evidenced that plaque may also be made of tubules obstructed by calcium phosphate plugs. Hypercalciuria has been associated to Randall’s plaque formation. However, several additional mechanisms may be involved resulting in increased tissular calcium phosphate supersaturation and the role of macromolecules in plaque formation remains elusive. At last, apatite crystals are the main mineral phase identified in plaques, but other calcium phosphates and various chemical species such as purines have been evidenced, revealing thereby that several mechanisms may be responsible for plaque formation.
Content may be subject to copyright.
1 3
Urolithiasis
DOI 10.1007/s00240-014-0703-y
INVITED REVIEW
Randall’s plaque as the origin of calcium oxalate kidney stones
Michel Daudon · Dominique Bazin ·
Emmanuel Letavernier
Received: 16 June 2014 / Accepted: 23 July 2014
© Springer-Verlag Berlin Heidelberg 2014
Keywords Randall’s plaque · Kidney stones · Calcium ·
Oxalate · Apatite
Introduction
Calcium oxalate (CaOx) stones are now identified as the
main type of urinary calculi in most countries through-
out the world. They account for at least 70 % of all stones
developed in the upper urinary tract and even more in male
patients [1]. In some parts of the world, CaOx was found as
the main component of about 90 % of all kidney stones [2].
Such a progression in CaOx stones accounts for the increase
in the prevalence of kidney stone disease frequently reported
during the past decades from countries where longitudinal
epidemiological surveys are available as in the United States
[3], in Europe [4, 5] or in Japan [6]. Among the risk factors
involved in stone formation, low diuresis and imbalance in
diet are well documented [79]. Although a lot of inherited
or acquired diseases may induce kidney stone formation, all
together account for less than 10–15 % of calcium stones in
the general population. Thus, most of calcium stones result
from biological disorders in urine such as hypercalciuria,
hyperoxaluria and/or hypocitraturia without any “identified”
pathology. Moreover, these disorders are inconstantly found
when urine biochemistry is performed, suggesting the anom-
alies are intermittent or transient, or simply related to low
diuresis, which results in an increased concentration of poorly
soluble salts in urine. Thus, the so-called idiopathic nephro-
lithiasis is the bulk of calcium stones. However, during the
last decade, a series of investigations by the group of Evan,
Lingeman and Coe, highlighted the role of calcium phosphate
deposits in the papilla tip as a starting point of CaOx stone
formation [1012]. Such deposits, termed Randall’s plaque
because they were first described by Alexander Randall in
Abstract Eight decades ago, Alexander Randall identi-
fied calcium phosphate deposits at the tip of renal papil-
lae as the origin of renal calculi. The awareness that these
“Randall’s plaque” promote renal stone formation has
been amplified during the past years by the development
of endoscopic procedures allowing the in situ visualization
of these plaques. Recent studies based upon kidney biop-
sies evidenced that apatite deposits at the origin of these
plaque originate from the basement membranes of thin
loops of Henle and then spread in the surrounding inter-
stitium. In addition, scanning electron microscopy exami-
nation of calcium oxalate stones developed on Randall’s
plaque evidenced that plaque may also be made of tubules
obstructed by calcium phosphate plugs. Hypercalciuria has
been associated to Randall’s plaque formation. However,
several additional mechanisms may be involved resulting
in increased tissular calcium phosphate supersaturation and
the role of macromolecules in plaque formation remains
elusive. At last, apatite crystals are the main mineral phase
identified in plaques, but other calcium phosphates and var-
ious chemical species such as purines have been evidenced,
revealing thereby that several mechanisms may be respon-
sible for plaque formation.
M. Daudon (*) · E. Letavernier
Laboratoire des Lithiases, Service des Explorations
Fonctionnelles, Hôpital Tenon, APHP, 4, rue de la Chine,
75970 Paris Cedex 20, France
e-mail: michel.daudon@tnn.aphp.fr
M. Daudon · E. Letavernier
Unité INSERM UMRS 1155, UPMC, Paris, France
D. Bazin
CNRS, Laboratoire de Chimie de la Matière Condensée de Paris,
UPMC, Collège de France, Paris, France
Urolithiasis
1 3
the 1930s, initiate in the basement membrane of the long
Henle’s loops and spread out in the interstitium around the
Bellini’s ducts close to the papillary epithelium. When the
epithelium is disrupted, the calcium phosphate deposits are in
contact with the supersaturated urine issued from the vicinal
nephrons, thus favouring CaOx crystallization and trapping of
the crystals at the surface of the plaque. Thereafter, the stone
growth is driven by urine supersaturation.
Original description of papillary calcified plaques
by Randall
More than 75 years ago, Alexander Randall reported a study
on “The origin and growth of renal calculi”, which appeared
first in the New England Journal of Medicine [13] and the
following year in the Annals of Surgery [14]. In this seminal
paper, he described a hitherto unrecognized papillary lesion
consisting in calcium phosphate deposits in the intertubular
spaces of the renal papilla, observed in 19.6 % of 1,154 pairs
of kidneys examined at autopsy. He made three observations:
first, this papillary lesion which appeared as a cream-
coloured area near the tip of the papilla was not on its
surface, but was subepithelial in location;
second, the chemical composition of papillary plaques
was shown to be made of calcium phosphate and car-
bonate;
third, small calculi were found to be attached to plaque
at the tip of papillae in 65 kidneys (2.8 %), their compo-
sition differing from that of the plaque. The stones were
made of calcium oxalate;
fourth, CaOx stones collected in routine practice often
exhibited a portion which was smooth and somewhat
depressed, resembling a facet corresponding with the
morphology of the papilla.
Examining by light microscopy some calculi actually
attached on a papillary plaque, Randall found that the stone
was continuous with the interstitial plaque and that the epi-
thelial covering of papilla was lost. Such aspect of calcium
phosphate deposits in the interstitium was termed papillary
lesion type 1 by Randall who proposed that papillary calcium
deposits could act as a nidus for urinary salt accretion if epi-
thelial covering of the papilla is lost. Randall also found in
some cases Bellini’s ducts filled by calcium phosphate plugs
(termed papillary lesion type 2). He suggested the phosphate
plugs may be another way for CaOx stone formation.
Scanning electron microscopy examination of CaOx stones
developed from a Randall’s plaque provides evidence that
plaque is made of a mixing of tubules with calcified walls
(white arrow, Fig. 1a) and of tubules obstructed by calcium
phosphate plugs (black arrow, Fig. 1a or white arrow, Fig. 1b).
Please note in Fig. 1b, the calcium phosphate cluster
within the tubular lumen (white arrow), while other tubules
are empty with calcified walls.
In other cases, much less frequent, the nidus of the stone
appears only as a tubular plug (Fig. 2, black arrow).
At the time Randall performed his studies, he could not
identify the exact location and nature of calcium depos-
its within the papillary structure. Nor, due to the forensic
nature of his study material, could he evaluate urinary sol-
ute excretion in the affected individuals.
Epidemiological considerations
Other authors confirmed the findings of Randall in autopsy
studies during the same period: for example, Rosenow
Fig. 1 Scanning electron microscopy photographs of calcium oxalate
calculi initiated from a Randall’s plaque. a The plaque is made of a
mixing of tubules with calcified walls (white arrow) and of tubules
obstructed by calcium phosphate plugs (black arrow). b Randall’s
plaque at the surface of another calcium oxalate stone with calcified
tubules and a calcium phosphate plug partly obstructing the lumen of
a collecting duct
Urolithiasis
1 3
found plaques in 22.2 % of 239 kidneys, whereas Anderson
observed plaques in 12 % of kidneys in a series of 1,500
necropsies [15, 16]. In South Africa, Vermooten [17] exam-
ined 1,060 pairs of kidneys. He found Randall’s plaques in
17.2 % of Caucasians and only 4.3 % of Bantus, a finding
in keeping with his observation of the lower incidence of
calcium nephrolithiasis in the local population of African
descent than Caucasian descent. Papillary calcifications
were seen in the subepithelial interstitial tissue together
with collagen fibres, and were not found in the lumen of
collecting ducts [18]. Forty years after the first description
of papillary calcified deposits acting as a nidus for calcium
stone formation, Luis Cifuentes-Delatte, a Spanish urolo-
gist enthusiastic for research on stone formation observed
with his colleagues that 142 out of 500 consecutive calculi
exhibited a concavity characteristic of a papillary origin
[19]. In 61 (43 %) of these umbilicated calculi, plaques
were typically made of apatite, some of them showing cal-
cified collecting ducts [20].
In our experience, based upon 45,774 calculi referred
to the Necker hospital stone laboratory over the past three
decades, we found by morphologic examination coupled
with FTIR analysis that 8,916 (19.5 %) calculi exhibited a
depressed surface (umbilication) suggestive of a papillary
attachment [21]. Most of these stones (92.5 %) were made
of CaOx monohydrate (whewellite) either pure (Fig. 3) or
admixed with CaOx dihydrate (weddellite) as observed in
Fig. 4. As previously reported, the composition of Randall’s
plaque is carbapatite in 90 % of cases, but other crystal-
line phases may be found as main component of Randall’s
plaque such as amorphous calcium phosphate, brushite or
whitlockite, or trioxypurines like sodium urate [19, 21].
However, detailed endoscopic examination of renal
cavities during percutaneous nephrolithotomy (PNL) or
ureteroscopic procedures suggests a much higher preva-
lence of Randall’s plaques than that deduced from stone
examination. An explanation could be that modern uro-
logical treatment to remove stones often use fragmenta-
tion techniques such as shockwaves, ultrasounds or laser.
As a consequence, stone fragments collected for analysis
may have lost both the part of Randall’s plaque fixed to the
stone and the typical depressed face. In 1997, using endo-
scopic procedures, Low and Stoller reported the presence
of Randall’s plaques on one or more papillae in 74 % of
57 stone formers, the prevalence being 88 % for CaOx
stones [22]. In 2006, Matlaga et al. [23] found that 91 %
of papillae in 23 patients with idiopathic CaOx nephrolithi-
asis harboured plaques and half of papillae had attached
calculi. Digital imaging provided undisputable evidence
of stone attachment to plaque. Indeed, epidemiological
differences in the occurrence of Randall’s plaques may be
Fig. 2 Scanning electron microscopy photograph of a tubular plug
(black arrow) at the origin of a calcium oxalate monohydrate stone
Fig. 3 Whewellite stone initiated from a carbapatite Randall’s plaque
(white arrow)
Fig. 4 Mixed stone made of whewellite and weddellite nucleated
from a Randall’s plaque (white arrow)
Urolithiasis
1 3
observed according to the investigated population. Recent
reports from European countries suggest that Randall’s
plaque could be less frequent in Europe than in the United
States. In Italy, Ruggera et al. reported the occurrence of
Randall’s plaque in 44.4 % of 27 stone formers who under-
went ureterorenoscopy or PNL and renal papillae biopsy
[24]. In France, Olivier Traxer found Randall’s plaques in
57 % of 287 stone formers who underwent flexible ureter-
orenoscopy. They were observed on all papillae in 54 % of
these patients. Such plaques were visible in only 27 % of
173 non-stone forming patients [25, 26].
Of note, in France, stones harbouring an umbilication
were found to be three times more frequent in the recent
years than at the beginning of the 1980s and patients were
younger and younger [27]. Children may form CaOx stones
from Randall’s plaque. As shown in Fig. 5, when consid-
ering only unfragmented stones spontaneously passed or
removed by urological procedures without fragmentation,
the part of stones developed from a Randall’s plaque is
very high and dramatically increasing with age from child-
hood up to the age class 20–30 years, then slowly decreas-
ing thereafter. In our experience, 39 % of all spontaneously
passed stones had a typical umbilication on their surface
and 5,728 among 8,662 (66.1 %) of spontaneously passed
CaOx monohydrate calculi were umbilicated and were
developed from a Randall’s plaque.
Randall’s plaques begin in basement membranes
of thin Henle’s loops
In an elegant study, Evan and co-workers recently pro-
vided substantial advances in the pathogenesis and struc-
ture of Randall’s plaques in patients with CaOx stones [10].
They took superficial biopsy specimens from papillae in
the upper, middle and lower poles of a kidney during PNL
performed for stone removal in 15 patients with recurrent,
idiopathic CaOx nephrolithiasis, all of whom were hyper-
calciuric, and in 4 patients with CaOx stones and hyperox-
aluria due to jejuno-ileal bypass for obesity.
By light microscopy, they confirmed Randall’s plaques
to be in subepithelial position at the papillary tip, surround-
ing the openings of the ducts of Bellini. Calcium-containing
deposits were found surrounding primarily the thin loops of
Henle. Electron microscopy revealed these deposits to be
located within the basement membrane of Henle’s loops
and around adjacent vasa recta, but not within the cyto-
plasm of the cells. Infrared microspectroscopy of deposits
identified spectral bands characteristics of hydroxyapatite,
associated with calcium carbonate in about 20 % of cases.
In summary, papillary plaques are interstitial and composed
of apatite, originate in the basement membrane of the thin
loops of Henle and subsequently spread into the surround-
ing interstitium, in the vasa recta and in the basement mem-
branes of collecting ducts, without affecting collecting
duct cells themselves. As said by the authors, “the overall
impression is that the basement membrane of thin limbs is
indeed the origin of plaque”.
In contrast, none of the four patients with enteric hyper-
oxaluria due to jejuno-ileal bypass exhibited such papillary
plaques. Instead, they exhibited intratubular hydroxyapatite
crystals in the lumen of some collecting ducts, attached to
their apical surface. Thus, the site of initial crystallization
differed according to the underlying metabolic abnormal-
ity. Of note, four non-stone-formers subjected to nephrec-
tomy, taken as controls, had neither papillary plaques nor
tubular crystals [10]. Looking for risk factors associated
with Randall’s plaque formation, Kuo et al. found that low
urine output, high calcium content and low urine pH were
significantly more frequent in calcium stone formers with
than without Randall’s plaque [28]. Moreover, Kim and co-
workers reported that stone episodes were proportional to
the coverage of papilla by Randall’s plaques [29].
Role of hypercalciuria in the pathogenesis of Randall’s
plaques
Evan and co-workers speculate that hypercalciuria should
be the main explanation at the origin of Randall’s plaques
[10]. Before examining their arguments, one may remem-
ber that an epidemiologic case/control study identified
high urinary calcium concentration to be the major risk
factor for idiopathic calcium nephrolithiasis [30], whereas
oxalate, uric acid and citrate concentrations did not differ
between incident stone formers and contemporary controls.
In the study of Evan et al. [10], the mean calcium excre-
tion was 312 mg/day (7.8 mmol/day) in the 15 CaOx stone
Fig. 5 Occurrence (%) of Randall’s plaque at the origin of spontane-
ously passed calcium oxalate stones according to the patient’s age
Urolithiasis
1 3
formers, compared to 113 mg/day (2.8 mmol/day, p < 0.01)
in the 4 non-lithiasic controls.
According to the authors and to the editorial comments of
their work by Bushinsky [31], the sequence of events could
be as follows. Hypercalciuria is associated with intestinal cal-
cium absorption, which results in postprandial peaks in serum
calcium, reflected in increased calcium concentration in glo-
merular filtrate and in the fluid presented to the thin limbs,
then to the thick ascending limb. High calcium reabsorption
at this site enriches the outer medulla with calcium, which is
washed into the deep medulla by the descending vasa recta.
The origin of calcium phosphate deposits in the inter-
stitium may be the consequence of several mechanisms. As
reported by Asplin and co-workers [32], the narrow part of
the long loops of Henle is often supersaturated for calcium
phosphate, which may precipitate. Despite the short tran-
sit time in that part of the nephron (20–30 s), where most
particles remain free in the tubular lumen, some of them
may be attached to the apical cell membrane, especially if
urinary macromolecules and other inhibitors such as citrate
are in low concentration or if an oxidative stress was able
to damage the cell surface. Then, an endocytosis process
may be initiated to eliminate them by intracellular dissolu-
tion [33]. Calcium and phosphate ions resulting from the
apatite dissolution are transferred in the interstitium and
may locally induce high CaP supersaturation favouring
new crystallization of apatite in the basement membrane
of thin limbs, which is unusually thick and is composed of
collagen with abundant mucopolysaccharides. Apatite crys-
tals, once initiated, are able to accumulate and extend in
the interstitium. At the microscopic scale, Evan et al. have
shown that apatite crystals are composed of successive lay-
ers of mineral and macromolecules such as osteopontin
[11]. Extensive accumulation of interstitial calcium depos-
its up to the papillary epithelium may result in a disruption
of the epithelium by a yet poorly understood mechanism,
thus making the apatite crystals exposed to the supersatu-
rated urine. In the first following steps, new layers of cal-
cium phosphate and macromolecules may cover the plaque,
after what CaOx crystals formed in the surrounding super-
saturated urine may be attached on the plaque, thus initiat-
ing stone formation [11, 26].
As underlined by Tiselius [34], calcium phosphate pre-
cipitation requires high CaP supersaturation, which is
favoured by high pH value, high concentration of calcium
and/or phosphate ions. Indeed, the physicochemical envi-
ronment in the interstitium of the inner medulla favours cal-
cium phosphate supersaturation around the tip of Henle’s
loops, especially in the presence of hypercalciuria and low
urine output. In case of an excessive acid load, as observed
in patients who eat large amounts of animal proteins, an
increased excretion of H
+
ions by the collecting duct cells
results in a low urine pH and an increased production of
bicarbonate ions transferred to the interstitium. High pro-
tein intake is also responsible for a high excretion of phos-
phate ions, which could be another favouring factor for
explaining calcium phosphate supersaturation in tubular
lumen and the papillary interstitium.
As a result of the high acid load (the same is observed
in the case of antidiuresis), the pH increases in the inner
medulla, inducing supersaturation of calcium phosphate
that may precipitate. Moreover, in hypercalciuric states,
which appear to be more frequent in patients with Randall’s
plaques, a default of calcium reabsorption in the proximal
part of the tubule results in an increased delivery of calcium
in the distal part of the nephron, which may contribute to
the supersaturation of calcium phosphate and/or CaOx
[35]. In the case of low diuresis, the hyaluronic acid content
in the inner medulla decreases [36] thus reducing its avail-
ability to act as an inhibitor of crystallization and results in
increased concentration of solutes in the interstitium.
While endocytosis of CaP particles or secondary precip-
itation of CaP in the basement membrane of the cells may
result from local high supersaturation, another phenom-
enon could explain why CaOx crystals may be secondary
deposited on the CaP Randall’s plaque after the papillary
epithelium has been lost by a yet unexplained mechanism.
Indeed, it is well known that CaP particles are the most fre-
quent mineral phases found in urine [37]. In the case of low
diuresis or high acid load, the secretion of H
+
in the distal
part of the nephron results in a rapid decrease of the pH
inducing dissolution of CaP particles. As a consequence,
an increased calcium concentration may increase enough
the CaOx supersaturation to induce nucleation of CaOx
crystals that are excreted in the caliceal cavities [3, 38] and
then may be fixed on the CaP particles at the surface of the
papilla [26]. Then, the stone growth depends on the level
of CaOx supersaturation, which is linked to the diuresis,
and the concentration of both calcium and oxalate, and also
of inhibitors such as citrate. When the stone is too large or
too heavy for the mechanical resistance of the Randall’s
plaque that plaque may be disrupted and the stone free in
the caliceal space. Thereafter, it may be rapidly spontane-
ously passed (the most frequent situation) or retained in the
calyx. In such case, new CaOx crystals may progressively
cover the umbilication and the calcium phosphate plaque,
which disappears at the surface of the stone. When removed
or spontaneously expelled, the stone does not exhibit any
Randall’s plaque which is found in the core of the stone as
suggested by Miller et al. [39] and illustrated in Fig. 6.
Randall’s plaque and stone composition
First studies by Evan and co-workers suggest that apatite
crystals are the mineral phase for interstitial plaque and
Urolithiasis
1 3
that amorphous calcium phosphate (ACP) deposits may
cover the plaque secondly after it outcrops at the surface
of the epithelium [11]. However, as suggested by Tiselius
[34] ACP formation is favoured by high CaP supersatura-
tion, which may occur not only in the urine, but also in
the interstitium. In fact, other works suggest that ACP may
be more abundant in the interstitial part of the Randall’s
plaque than at its surface [40]. As previously reported,
Randall’s plaque is made of carbapatite in most cases, but
other calcium phosphates and other chemical species, such
as sodium urate may be identified within Randall’s plaque
[21]. As shown in Table 1, about 15 different crystalline
species were found among 11,016 calculi exhibiting a pap-
illary umbilication. Carbapatite was identified in 97.6 %
of cases, either pure or mixed with other calcium phos-
phates or other compounds such as purines. However, in
some cases, carbapatite was not detected and then, another
mechanism than Randall’s plaque may be involved in
stone formation. We cannot exclude that some of these
compounds such as uric acid were only deposited at the
surface of the papilla because of a local tissue lesion and
then acted as a factor for heterogeneous nucleation of cal-
cium oxalate. Of note, around the Randall’s plaque the first
layers of the stone are made in most cases by CaOx mono-
hydrate [21, 38].
Conclusion
Idiopathic CaOx stones, the occurrence of which has
been frequently reported as increasing during the past
half century, mainly from a Randall’s plaque made of
carbapatite. In parallel, the progress in endoscopic mate-
rial and optics, making easy the visual inspection of kid-
ney papillae provides evidence that Randall’s plaques
are become very common in stone formers as in the gen-
eral population. Such changes are in line with in-depth
modifications in dietary habits in industrialized coun-
tries over the past decades. A better knowledge regard-
ing the mechanisms involved in the formation of calci-
fied deposits within the inner medulla of the kidney is
required in order to provide efficient advices able to
reduce the occurrence of Randall’s plaque and stone
formation.
Fig. 6 Section of a whewellite stone exhibiting a whitish core made
of carbapatite containing holes highly suggestive of Randall’s plaque
with calcified tubules
Table 1 Occurrence of
crystalline species found as
Randall’s plaque at the stone
surface
Components of papillary deposits Main Minor Total occurrence
Calcium phosphates 10716 (97.3) 10894 (98.9)
Carbapatite 10404 (94.4) 351 (3.2) 10755 (97.6)
Amorphous carbonated calcium phosphate 264 (2.4) 629 (5.7) 893 (8.1)
Whitlockite 30 (0.3) 87 (0.8) 117 (1.0)
Octacalcium phosphate 3 (0.03) 13 (0.12) 16 (0.15)
Brushite 15 (0.14) 23 (0.2) 38 (0.34)
Other species 300 (2.7) 503 (4.6)
Struvite 3 (0.03) 9 (0.08) 12 (0.1)
Bobierrite 2 (0.02) 0 2 (0.02)
Calcite 9 (0.08) 12 (0.1) 21 (0.2)
Sodium hydrogen urate 232 (2.1) 138 (1.25) 370 (3.4)
Uric acid 43 (0.4) 24 (0.2) 67 (0.6)
Ammonium urate 4 (0.04) 3 (0.03) 7 (0.06)
Potassium urate 4 (0.04) 0 4 (0.04)
Opaline silica 2 (0.02) 1 (0.01) 3 (0.03)
Porphyrines 1 (0.01 16 (0.15) 17 (0.15)
Total number of samples 11016 (100) 1291 (11.7)
Urolithiasis
1 3
Conflict of interest The authors declare no conflict of interest.
References
1. Curhan GC (2007) Epidemiology of stone disease. Urol Clin
North Am 34:287–293
2. Ansari MS, Gupta NP, Hemal AK, Dogra PN, Seth A, Aron M,
Singh TP (2005) Spectrum of stone composition: structural anal-
ysis of 1050 upper urinary tract calculi from northern India. Int J
Urol 12(1):12–16
3. Denstedt JD, Fuller A (2012) Epidemiology of stone disease in
North America. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds)
Urolithiasis: basic science and clinical practice. Springer, Lon-
don, pp 13–20
4. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P (2003)
Study on the prevalence and incidence of urolithiasis in Germany
comparing the years 1979 vs. 2000. Eur Urol 44:709–713
5. Trinchieri A (2006) Epidemiological trends in urolithiasis: impact
on our health care systems. Urol Res 34:151–156
6. Ogawa Y (2012) Epidemiology of stone disease over a 40-year
period in Japan. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds)
Urolithiasis: basic science and clinical practice. Springer, Lon-
don, pp 89–96
7. Siener R (2006) Impact of dietary habits on stone incidence. Urol
Res 34:131–133
8. Asselman M, Verkoelen CF (2008) Fructose intake as a risk fac-
tor for kidney stone disease. Kidney Int 73:139–140
9. Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet asso-
ciates with reduced risk for kidney stones. J Am Soc Nephrol
20:2253–2259
10. Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of
patients with nephrolithiasis begins in basement membranes of
thin loop of Henle. J Clin Invest 111:607–616
11. Evan AP, Coe FL, Lingeman JE et al (2007) Mechanism of for-
mation of human calcium oxalate renal stones on Randall’s
plaque. Anat Rec (Hoboken) 290:1315–1323
12. Evan AP, Lingeman JE, Worcester EM, et al. Contrasting histopa-
thology and crystal deposits in kidneys of idiopathic stone form-
ers who produce hydroxy apatite, brushite, or calcium oxalate
stones. Anat Rec (Hoboken). 2014 Jan 30. doi:10.1002/ar.22881.
[Epub ahead of print]
13. Randall A (1936) An hypothesis for the origin of renal calculus.
N Engl J Med 214:234–237
14. Randall A (1937) The origin and growth of renal calculi. Ann
Surg 105:1009–1027
15. Rosenow EC Jr (1940) Renal calculi: study of papillary calcifica-
tion. J Urol 44:19–28
16. Anderson WAD (1940) Renal calcification in adults. J Urol
44:29–34
17. Vermooten V (1941) The incidence and significance of the
deposition of calcium plaques in the renal papilla as observed
in the Caucasian and Bantu population in South Africa. J Urol
46:193–196
18. Vermooten V (1942) Origin and development in renal papilla of
Randall’s calcium plaques. J Urol 48:27–37
19. Cifuentes-Delatte L, Minon-Cifuentes J, Medina JA (1987) New
studies on papillary calculi. J Urol 137:1024–1029
20. Cifuentes-Delatte L, Minon-Cifuentes JL, Medina JA (1985)
Papillary stones: calcified renal tubules in Randall’s plaques. J
Urol 133:490–494
21. Daudon M, Traxer O, Jungers P, Bazin D. Stone morphology sug-
gestive of Randall’s plaque. In: Evan AP, Lingeman JE, Williams
JC Jr (eds): Renal stone disease. American Institute of Physics
Conference Proceedings, Melville, New York, 2007, vol 900, pp.
2634
22. Low RK, Stoller ML (1997) Endoscopic mapping of renal papil-
lae for Randall’s plaques in patients with urinary stone disease. J
Urol 158:2062–2064
23. Matlaga BR, Williams JC Jr, Kim SC et al (2006) Endoscopic
evidence of calculus attachment to Randall’s plaque. J Urol
175:1720–1724
24. Ruggera L, Chiodini S, Gambaro G, et al. (2008) Does Randall’s
plaque represent a necessary condition in the pathogenesis of the
idiopathic calcium oxalate stones? In: Abstracts of the 11th inter-
national symposium on urolithiasi, Nice, 2–5 September 2008.
Urol Res, vol 36, pp 162–163 (A)
25. Carpentier X, Daudon M, Bazin D, Traxer O (2009) Plaques de
Randall: fréquence, topographie et classification. Sémin Urol
Néphrol 35:86–90
26. Daudon M, Traxer O, Williams JC, Bazin DC (2011) Randall’s
plaques. In: Rao PN, Preminger GM, Kavanagh JP (eds) Urinary
tract stone disease. Springer, London, pp 103–112
27. Daudon M (2005) Épidémiologie actuelle de la lithiase rénale en
France. Ann Urol 39:209–231
28. Kuo RL, Lingeman JE, Evan AP et al (2003) Urine calcium and
volume predict coverage of renal papilla by Randall’s plaque.
Kidney Int 64:2150–2154
29. Kim SC, Coe FL, Tinmouth WW et al (2005) Stone formation is
proportional to papillary surface coverage by Randall’s plaque. J
Urol 173:117–119
30. Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001)
Twenty-four-hour urine chemistries and the risk of kidney stones
among women and men. Kidney Int 59:2290–2298
31. Bushinsky DA (2003) Nephrolithiasis: site of the initial solid
phase. J Clin Invest 111:602–605
32. Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium
phosphate supersaturation in the loop of Henle. Am J Physiol
270:F604–F613
33. Lieske JC, Norris R, Swift H, Toback FG (1997) Adhesion, inter-
nalization and metabolism of calcium oxalate monohydrate crys-
tals by renal epithelial cells. Kidney Int 52:1291–1301
34. Tiselius HG (2013) The role of calcium phosphate in the develop-
ment of Randall’s plaques. Urolithiasis 41:369–377
35. Worcester EM, Coe FL, Evan AP et al (2008) Evidence for
increased postprandial distal nephron calcium delivery in hyper-
calciuric stone forming patients. Am J Physiol Renal Physiol
295:F1286–F1294
36. Hansell P, Goransson V, Odlind C, Gerdin B, Hallgren R (2000)
Hyaluronan content in the kidney in different states of body
hydration. Kidney Int 58:2061–2068
37. Smith LH, Werness PG (1983) Hydroxyapatite—the forgot-
ten crystal in calcium urolithiasis. Trans Am Clin Chem Assoc
95:183–190
38. Sethmann I, Grohe B, Kleebe HJ (2014) Replacement of hydrox-
ylapatite by whewellite: implications for kidney-stone formation.
Mineral Mag 78:91–100
39. Miller NL, Williams JC Jr, Evan AP et al (2010) In idiopathic cal-
cium oxalate stone-formers, unattached stones show evidence of
having originated as attached stones on Randall’s plaque. BJU Int
105:242–245
40. Carpentier X, Bazin D, Jungers P, Reguer S, Thiaudière D,
Daudon M (2010) The pathogenesis of Randall’s plaque: a
papilla cartography of Ca compounds through an ex vivo inves-
tigation based on XANES spectroscopy. J Synchrotron Radiat
17:374–379
... No researchers have analyzed kidney stones and PPIs use through the NHANES database, and previous studies have been partial to blaming abnormal urine composition for the development of kidney stones. CaOx kidney stones are the most common kidney stone, and their origin is closely related to RP [3,31]. Furthermore, oxidative stress and inflammatory response caused by calcium phosphate (CaP) deposition in the renal papilla can accelerate the growth of RP [32]. ...
Article
Full-text available
Background Proton pump inhibitors (PPIs) are widely used throughout the world as an effective gastrointestinal drug. Nevertheless, according to the existing literature, PPIs can reduce the excretion of magnesium, calcium and other components in urine, which may promote the formation of kidney stones. We used the National Health and Nutrition Examination Survey (NHANES) database to further investigate the association between the use of PPIs and the prevalence of kidney stones. Methods We performed a cross-sectional analysis using data from 2007 to 2018 NHANES. PPIs use information of 29,910 participants was obtained by using prescription medications in the preceding month, and kidney stones were presented by a standard questionnaire. Multiple regression analysis and stratified analysis were used to estimate the association between PPIs use and kidney stones after an adjustment for potential confounders. Results The multiple logistic regression indicated that the PPIs exposure group (P1) had a significantly higher risk of nephrolithiasis than the PPIs non-exposure group (P0) in Model 3 (OR 1.24, 95% CI 1.10–1.39, P < 0.001). The stratified analyses indicated there were significant statistical differences between PPIs use and kidney stones among females (OR 1.36, 95% CI 1.15–1.62, P < 0.001), non-Hispanic whites (OR 1.27, 95% CI 1.09–1.48, P = 0.002), individuals with an education level than 11th grade (OR 1.41, 95% CI 1.13–1.76, P = 0.002) and individuals with an annual family income of $0 to $19,999 (OR 1.32, 95% CI 1.06–1.65, P = 0.014) and $20,000 to $44,999 (OR 1.25, 95% CI 1.02–1.54, P = 0.033) in Model 3. Conclusions Our study revealed that PPIs use is associated with a higher prevalence of kidney stones for the US population, primarily among women, non-Hispanic whites, individuals with low education levels and individuals with low household income levels. Further studies are required to confirm our findings.
... In fact, the COM and COD forms are the main constituents of the majority of urinary stones. 6,7 There is a growing interest in studying the crystallization of CaOx in vitro and in vivo using solid templates, additives, and herbal plants, to elucidate the mechanism involved in urolithiasis disease and to fabricate hierarchical hybrid materials. 8−16 Thus, citrate, for example, can affect the crystallization process by interacting electrostatically with certain phases of CaOx crystals. ...
Article
Full-text available
Calcium oxalate (CaOx) is known to grow on organic matrices and is often associated with the formation of kidney stones. Therefore, it is crucial to understand the nucleation and growth mechanisms. This study investigates the role of electrospun polycaprolactone (PCL)-loaded zarzaparrilla (ZP) (Herreria stellata) in the electrocrystallization (EC) of CaOx. Electrospinning (ES) was used to prepare PCL meshes with random (R) and aligned (A) fiber orientations. CaOx particles were grown directly on conductive tin indium oxide (ITO) glass modified with electrospun ZP-loaded PCL meshes by EC. The CaOx crystals after EC were measured by chronopotentiometry (CP), optical microscopy (OM), scanning electron microscopy (SEM), and X-ray diffraction (XRD), which showed that the ZP additive and PCL fiber orientations are key factors for CaOx nucleation.
... [15] There have been CaP and purine (apatite) crystal compositions in plaques but apatite predominates. [48] Randall plaques, which have been made up of CaP crystals and organic matrix, form anywhere along basement membranes of the relatively small loops of Henle before trying to spread out across the interstitial space and eventually reaching the urothelium. There is evidence that the creative stone made of CaOx is secondary to the formation of interstitial apatite crystals. ...
Article
Kidney stones (calculi) comprise mineral concretions which can form in both renal calyces and pelvis and can be free floating or associated with the renal papillae. It is an emerging urological condition that affects around 12% of the world’s population. Globally, the prevalence and recurrence of kidney stone disease are increasing, and there are limited effective treatment options. I manifest a brief general overview and then concentrate on risk factors, pathophysiology, and medical treatment of kidney stones. The major component of most stones is calcium oxalate, and many of them develop on a foundation of calcium phosphate known as Randall’s plaques, which are located on the renal papillary surface. The mechanism of stone formation is a complicated process that involves multiple physicochemical phenomena such as supersaturation, nucleation, growth, aggregation, and retention of urinary stone ingredients inside tubular cells. Cellular damage is also thought to enhance particle retention on renal papillary surfaces. There is currently no effective treatment or prevention for kidney stone recurrence. Recurrence prevention required behavioral and nutritional interventions, as significantly as pharmaceutical therapies tailored to the kind of stone. There is a great demand for recurrence prevention, which necessitates a deeper knowledge of the processes involved in the development of stones to design more effective medications. Open surgical lithotomy has given way to minimally invasive endourological procedures for the treatment of symptomatic kidney stones, resulting in lower patient morbidity, increased stone-free rates, and enhanced quality of life. As a result, furthering our knowledge of the biology of kidney stone development is a research focus for treating urolithiasis with novel medications.
... In 1936, the American urologist Alexander Randall described the presence of calcium phosphate deposits at the tip of the renal papilla. He also observed calcium oxalate renal stones connected to the plaques and put forward the hypothesis that these papillary calcifications could potentially be the initial trigger for stone formation in these patients [65,66]. Recently, it was found that these plaques have a 83% prevalence in kidney stone formers [67]. ...
Article
Full-text available
Purpose Urolithiasis has become increasingly prevalent, leading to higher disability-adjusted life years and deaths. Various stone classification systems have been developed to enhance the understanding of lithogenesis, aid urologists in treatment decisions, and predict recurrence risk. The aim of this manuscript is to provide an overview of different stone classification criteria. Methods Two authors conducted a review of literature on studies relating to the classification of urolithiasis. A narrative synthesis for analysis of the studies was used. Results Stones can be categorized based on anatomical position, size, medical imaging features, risk of recurrence, etiology, composition, and morphoconstitutional analysis. The first three mentioned offer a straightforward approach to stone classification, directly influencing treatment recommendations. With the routine use of CT imaging before treatment, precise details like anatomical location, stone dimensions, and Hounsfield Units can be easily determined, aiding treatment planning. In contrast, classifying stones based on risk of recurrence and etiology is more complex due to dependencies on multiple variables, including stone composition and morphology. A classification system based on morphoconstitutional analysis, which combines morphological stone appearance and chemical composition, has demonstrated its value. It allows for the rapid identification of crystalline phase principles, the detection of crystalline conversion processes, the determination of etiopathogenesis, the recognition of lithogenic processes, the assessment of crystal formation speed, related recurrence rates, and guidance for selecting appropriate treatment modalities. Conclusions Recognizing that no single classification system can comprehensively cover all aspects, the integration of all classification approaches is essential for tailoring urolithiasis patient-specific management.
... Our spatial transcriptomic mapping of gene expression in stone disease agrees with, and extends the work of Taguchi and colleagues, who explored genome-wide analysis of gene expression on renal papillary Randall's Plaques (RP), and non-RP, and showed upregulation of LCSN2, IL11, and PTGS1 in the RP patient tissue 7 . RP has been previously described as the interstitial mineral deposition at the tip of the renal papillae that can serve as the origin for CaOx stone growth 35,36 . This immune active state in the regions of papillary mineralization has a molecular profile comparable to vascular inflammation leading to atherosclerotic disease, which has been proposed to play a pathogenic role in mineral deposition and stone disease [37][38][39][40] . ...
Article
Full-text available
Kidney stone disease causes significant morbidity and increases health care utilization. In this work, we decipher the cellular and molecular niche of the human renal papilla in patients with calcium oxalate (CaOx) stone disease and healthy subjects. In addition to identifying cell types important in papillary physiology, we characterize collecting duct cell subtypes and an undifferentiated epithelial cell type that was more prevalent in stone patients. Despite the focal nature of mineral deposition in nephrolithiasis, we uncover a global injury signature characterized by immune activation, oxidative stress and extracellular matrix remodeling. We also identify the association of MMP7 and MMP9 expression with stone disease and mineral deposition, respectively. MMP7 and MMP9 are significantly increased in the urine of patients with CaOx stone disease, and their levels correlate with disease activity. Our results define the spatial molecular landscape and specific pathways contributing to stone-mediated injury in the human papilla and identify associated urinary biomarkers.
Article
Full-text available
Ferroptosis is a specific type of programmed cell death characterized by iron-dependent lipid peroxidation. Understanding the involvement of ferroptosis in calcium oxalate (CaOx) stone formation may reveal potential targets for this condition. The publicly available dataset GSE73680 was used to identify 61 differentially expressed ferroptosis-related genes (DEFERGs) between normal kidney tissues and Randall's plaques (RPs) from patients with nephrolithiasis through employing weighted gene co-expression network analysis (WGCNA). The findings were validated through in vitro and in vivo experiments using CaOx nephrolithiasis rat models induced by 1% ethylene glycol administration and HK-2 cell models treated with 1 mM oxalate. Through WGCNA and the machine learning algorithm, we identified LAMP2 and MDM4 as the hub DEFERGs. Subsequently, nephrolithiasis samples were classified into cluster 1 and cluster 2 based on the expression of the hub DEFERGs. Validation experiments demonstrated decreased expression of LAMP2 and MDM4 in CaOx nephrolithiasis animal models and cells. Treatment with ferrostatin-1 (Fer-1), a ferroptosis inhibitor, partially reversed oxidative stress and lipid peroxidation in CaOx nephrolithiasis models. Moreover, Fer-1 also reversed the expression changes of LAMP2 and MDM4 in CaOx nephrolithiasis models. Our findings suggest that ferroptosis may be involved in the formation of CaOx kidney stones through the regulation of LAMP2 and MDM4.
Article
Effective prevention of recurrent kidney stone’s diseases requires the understanding of their mechanisms of formation. Numerous in vivo observations have demonstrated that a large number of pathological calcium oxalate kidney...
Article
Full-text available
Urolithiasis is a common urological disease with increasing prevalence and high recurrence rates around the world. Numerous studies have indicated reactive oxygen species (ROS) and oxidative stress (OS) were crucial pathogenic factors in stone formation. Dietary polyphenols are a large group of natural antioxidant compounds widely distributed in plant-based foods and beverages. Their diverse health benefits have attracted growing scientific attention in recent decades. Many literatures have reported the effectiveness of dietary polyphenols against stone formation. The antiurolithiatic mechanisms of polyphenols have been explained by their antioxidant potential to scavenge free radicals and ROS, modulate the expression and the activity of endogenous antioxidant and prooxidant enzymes, regulate signaling pathways associated with OS, and maintain cell morphology and function. In this review, we first describe OS and its pathogenic effects in urolithiasis and summarize the classification and sources of dietary polyphenols. Then, we focus on the current evidence defining their antioxidant potential against stone formation and put forward challenges and future perspectives of dietary polyphenols. To conclude, dietary polyphenols offer potential applications in the treatment and prevention of urolithiasis.
Chapter
Calcium-containing stones are the most common form of nephrolithiasis and account for about 80% of all renal stones. This condition most often occurs in the fifth to sixth decades of life and is more common in men than women (M:F ratio, 2.25:2.62). A hospital-based survey performed in Japan over a 40-year period (1965–2005) showed an increase in the annual incidence of urolithiasis (from 437 to 1,340/million) and its lifetime prevalence (from 4.0 to 10.8%). Shockwave lithotripsy is the mainstay for treatment of stones in the upper urinary tract (90.9%), followed by transurethral ureterolithotripsy, percutaneous nephrolithotomy, and open surgery. Reviewing the 40-year period, accumulated evidence suggests the importance of lifestyle modification by correcting a Westernized diet, insufficient fluid intake, and poor physical activity for prevention of urolithiasis.
Chapter
Despite recent advances in the surgical techniques and equipment available for the management of urinary lithiasis, the prevalence of this condition continues to increase in the North American population. Associated costs are estimated to exceed 5.3 billion US dollars each year. Epidemiological studies have implicated a range of contributory dietary, medical, environmental, and genetic factors in the pathophysiology of this disease. Many of these factors are consistent internationally. Despite this, the North American population, with its associated racial, environmental, and socioeconomic diversity, provides unique epidemiological insights. This chapter provides an overview of the risk factors for stone disease as well as incidence and prevalence patterns in a North American context using contemporary data.
Article
Background. Results of a 24-hour urine collection are integral to the selection of the most appropriate intervention to prevent kidney stone recurrence. However, the currently accepted definitions of normal urine values are not firmly supported by the literature. In addition, little information is available about the relationship between risk of stone formation and the levels of urinary factors. Unfortunately, the majority of previous studies of 24-hour urine chemistries were limited by the inclusion of recurrent stone formers and poorly defined controls. Methods. We obtained 24-hour urine collections from 807 men and women with a history of kidney stone disease and 239 without a history who were participants in three large ongoing cohort studies: the Nurses' Health Study I (NHS I; mean age of 61 years), the Nurses' Health Study II (NHS II; mean age of 42 years), and the Health Professionals Follow-up Study (HPFS; mean age of 59 years). Results. Mean 24-hour urine calcium excretion was higher and urine volume was lower in cases than controls in NHS I (P less than or equal to 0.01), NHS II (P less than or equal to 0.13) and HPFS (P less than or equal to 0.01), but urine oxalate and citrate did not differ. Among women, urine uric acid was similar in cases and controls but was lower in cases in men (P = 0.06). The frequency of hypercalciuria was higher among the cases in NHS I (P = 0.26), NHS II (P = 0.03), and HPFS (P = 0.02), but 27, 17, and 14% of the controls, respectively, also met the definition of hypercalciuria. The frequency of hyperoxaluria did not differ between cases and controls, but was three times more common among men compared with women. After adjusting for the other urinary factors, the relative risk of stone formation increased with increasing urine calcium levels and concentration in all three cohorts but not in a linear fashion. Compared with individuals with a urine calcium concentration of <75 mg/L, the relative risk of stone formation among those with a urine calcium concentration of 200 mg/L for NHS I was 4.34 (95% CI, 1.59 to 11.88), for NHS II was 51.09 (4.27 to 611.1), and for HPFS was 4.30 (1.71 to 10.84). There was substantial variation in the relative risks for stone formation for the concentration of other urine factors within the different cohorts. Conclusions. The traditional definitions of normal 24-hour urine values need to be! reassessed, as a substantial proportion of controls would be defined as abnormal, and the association with risk of stone formation may be continuous rather than dichotomous. The 24-hour urine chemistries are important for predicting risk of stone formation, but the significance and the magnitudes of the associations appear to differ by age and gender.
Article
Kidney stones consisting predominantly of whewellite (calcium oxalate monohydrate, COM) are often found attached to hydroxylapatite (HA) plaques that form in the soft tissue of kidneys, cause lesions and become exposed to urine. Although the processes of stone formation are not entirely known, it is an established view that so-called Randall’s plaques serve as substrates for COM crystal nucleation and growth from correspondingly supersaturated urine. However, the results presented here suggest an additional mineral replacement process is involved. In an experimental approach, HA was reacted in 0.25 mM, 0.5 mM and 1.0 mM oxalate solutions with pH ranging from 4.5 to 7.5, simulating normal to harsh conditions encountered in urine. Extremely acidic solutions induce dissolution of HA crystals coupled with re-precipitation of the released Ca2+ ions as COM on the HA surface. When, instead, bone was used as a substrate, being more similar to the pathological plaque (aggregated HA nanocrystals within an organic matrix), the HA-COM mineral-replacement reaction is induced even under much milder fluid conditions, commonly found in urine. Hence, a process of COM partly replacing and encrusting Randall’s plaque may take place in the urinary tract of idiopathic stone formers, representing a potential starting event for nephrolithiasis.